Zoll Surges as Defibrillator Vest Keeps Medicare Coverage
This article is for subscribers only.
Zoll Medical Corp., a maker of resuscitation devices, rose the most in almost two decades after Medicare said it will continue to cover the company’s wearable LifeVest defibrillator.
Zoll climbed 29 percent to $60.29 at the close in New York, the biggest single-day increase since the company first offered shares to the public in July 1992. Administrators with Medicare, the U.S. health-care program for the elderly and disabled, withdrew a proposed reimbursement change that would have delayed use of LifeVest, which has been covered since 2005, Chelmsford, Massachusetts-based Zoll said in a statement.